Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pandemics
Recent news which mentions Pandemics
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
California will not renew $54 million contract with Walgreens over abortion pill policy
March 09, 2023
Tags
Business News
U/S/ Economy
Disease outbreaks
From
CNBC.com News
Career expert Suzy Welch: Use these tips to recession-proof your job and avoid getting laid off
March 09, 2023
Tickers
JOBS
Tags
Savings
Pandemics
Jobs
From
CNBC.com News
Eli Lilly Alzheimer's treatment solanezumab failed to slow disease progression
March 08, 2023
Tags
Business News
U/S/ Economy
Disease outbreaks
From
CNBC.com News
Florida state lawmakers introduce bill that would ban abortion after six weeks
March 07, 2023
Tags
US Top News and Analysis
Health care industry
US Economy
From
CNBC.com News
FDA powers don't override state abortion pill bans, Republican attorneys general argue in West Virginia lawsuit
March 07, 2023
Tags
Business News
U/S/ Economy
Disease outbreaks
From
CNBC.com News
California governor says state won't do business with Walgreens over position on abortion pill
March 06, 2023
Tags
Biotech and Pharmaceuticals
US Top News and Analysis
Retail
From
CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
March 06, 2023
Tags
Biotechnology
Politics
Eisai Co Ltd
From
CNBC.com News
'Huge hunger cliff' looms, warns expert: Average recipient to get $90 less in food stamps as Covid aid ends
March 02, 2023
Tags
Snap Inc
Hunger
Pandemics
From
CNBC.com News
FDA advisors recommend GSK's RSV vaccine for older adults, but flag potential safety risks
March 01, 2023
Tags
Business News
U/S/ Economy
Disease outbreaks
From
CNBC.com News
Lilly to cut insulin prices by 70%, cap prices at $35 per month for people with private insurance
March 01, 2023
Tags
Eli Lilly and Co
Health & Science
US: News
From
CNBC.com News
FDA advisors recommend Pfizer RSV vaccine for older adults, despite possible Guillain-Barre risks
February 28, 2023
Tags
Policy
Breaking News: Business
Coronavirus
From
CNBC.com News
Watch live: Biden warns of GOP plans to curb access to health-care
February 28, 2023
Tags
Health & Science
Pharmaceuticals
Pandemics
From
CNBC.com News
Op-ed: DEA and FDA rules exacerbate Adderall shortage
February 28, 2023
Tags
Attention deficit disorders
Politics
Biotechnology
From
CNBC.com News
Democratic attorneys general sue FDA to drop all remaining restrictions on abortion pill
February 24, 2023
Tags
US: News
World News
Business
From
CNBC.com News
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adults
February 24, 2023
Tags
US Top News and Analysis
Biotech and Pharmaceuticals
Disease outbreaks
From
CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
February 23, 2023
Tags
Business
Pandemics
World News
From
CNBC.com News
Moderna misses on earnings as costs rise from surplus production capacity, lower demand for Covid shots
February 23, 2023
Tags
Moderna Inc
Biotech and Pharmaceuticals
US Top News and Analysis
From
CNBC.com News
West Virginia asks judge to dismiss lawsuit seeking to overturn state restrictions on abortion pill
February 22, 2023
Tags
US Top News and Analysis
US Economy
Health care industry
From
CNBC.com News
CDC advisors recommend mpox vaccine for at-risk adults in future outbreaks
February 22, 2023
Tags
Biotech and Pharmaceuticals
US Top News and Analysis
Health care industry
From
CNBC.com News
Flu vaccine was 68% effective at preventing hospitalization in children, but less protective for seniors this season
February 22, 2023
Tags
US Economy
Health care industry
US Top News and Analysis
From
CNBC.com News
Pfizer RSV vaccine that protects infants could receive FDA approval this summer
February 21, 2023
Tags
Policy
Breaking News: Business
Coronavirus
From
CNBC.com News
Watch live: Biden speaks in Poland ahead of one-year anniversary of Russia's war in Ukraine
February 21, 2023
Tags
Disease outbreaks
Markets
Biotech and Pharmaceuticals
From
CNBC.com News
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
February 17, 2023
Tags
Biotech and Pharmaceuticals
Health care industry
US Economy
From
CNBC.com News
Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage
February 17, 2023
Tags
Health & Science
US: News
World News
From
CNBC.com News
Watch live: Biden addresses nation on Chinese spy balloon, other aerial phenomena
February 16, 2023
Tags
Politics
Biotechnology
Coronavirus
From
CNBC.com News
FDA advisors recommend over-the-counter use of life-saving opioid overdose treatment Narcan
February 15, 2023
Tags
Coronavirus
Epidemics
Policy
From
CNBC.com News
Moderna CEO Stephane Bancel will testify before Senate next month on Covid vaccine price hike
February 15, 2023
Tags
Politics
Biotechnology
Coronavirus
From
CNBC.com News
Watch live: Biden outlines plans to cut U.S. deficit by $2 trillion over the next decade
February 15, 2023
Tags
Economic events
Pharmaceuticals
Pandemics
From
CNBC.com News
House GOP asks Fauci and dozens of health officials to testify in investigation into Covid origins
February 14, 2023
Tags
US Economy
Health care industry
US Top News and Analysis
From
CNBC.com News
Op-ed: U.S. inflation and jobs reports shows fastest recovery in 30 years under Biden
February 14, 2023
Tags
Biotech and Pharmaceuticals
Health care industry
Congress
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.